-
The global waiver that was granted to Rhode Island in 2009 allows the state to operate its Medicaid program in a way that is different than otherwise required under statute and still receive federal matching funds, according to Elena Nicolella, the state's Medicaid director.
-
When a single imported case of measles led to a small outbreak in Tucson, AZ, in 2008, two hospitals were forced to spend a total of some $800,000 to contain it, much of that related to ensuring the immunity of employees.
-
Having finally wrested a seat at the C-suite table, infection preventionists are now poised to move to the patient bedside. A profession that has labored in relative obscurity for much of its existence is at a critical juncture with a host of influential agents who are suddenly very interested in infection prevention: patients, consumer advocates, state and federal regulators. A path to empowerment has opened.
-
With pathogens like Clostridium difficile and multidrug-resistant Acinebactor which can linger on surfaces and fomites for prolonged periods the health care environment is among the top priority research areas to prevent health care associated infections (HAIs).
-
-
Katrina Crist, MBA, was recently named the new chief executive officer at the Association for Professionals in Infection Control & Epidemiology in Washington, DC.
-
"Sand; tiny, discrete particles with substance but basically without fixed structure, frequently accumulating in forms of great beauty or built into 'castles.' In this elemental form sand, and data, present great danger, able to blind us or even bury us." Walter J Hierholzer, Jr., MD
-
In this double-blind protocol, normal-weight (body mass index [BMI] 19.0-24.9 kg/m2) and obese (BMI 30.0-39.9 kg/m2) women with regular periods and normal ovarian ultrasound took one of two types of oral contraceptives (OCPs): either 21-day monophasic pills with 20 mcg ethinyl estradiol/100 mcg levonorgestrel or 30 mcg ethinyl estradiol/150 mcg levonorgestrel.
-
In this issue: ACEI/ARB therapy for AS; safety alert issued for dronedarone; statins and cancer risk; nesiritide and heart failure; and FDA actions.
-